A novel manufacturing process for the Net-Zero separation and purification of biobased cadaverine for sustainable fashion application
用于可持续时尚应用的生物基尸胺净零分离和纯化的新型制造工艺
基本信息
- 批准号:10063534
- 负责人:
- 金额:$ 10.73万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Collaborative R&D
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In recent years, the energy crisis has become increasingly serious. Global warming and the shortage of fossil resources has driven the quest for a new bio-economy. Cadaverine is a bio-based platform chemical that plays an indispensable role in industry, medicine and agriculture. In particular, cadaverine is an important polymer monomer for polyamides and polyurethanes. Due to the similar structure of cadaverine and 1,6-diaminohexane, cadaverine can replace 1,6-diaminohexane to synthesize bio-based polyamide materials such as nylon 54, nylon 56, nylon 510 and nylon 512\. Compared to traditional nylons, the new nylons made from cadaverine have a lower density, better dimensional stability and other superior properties. For example, nylon56 has a significant advantage in producing textile fibres owing to its low glass transition temperature and high water absorption. The low glass transition temperature enables nylon 56 fiber to perform well in alpine regions\[1\], and greatly improves the low-temperature resistance of the material. The high absorption rate gives nylon 56fiber good moisture-wicking performance, significantly improving wearing comfort and reducing static electricity. In addition, nylon 56 has excellent strength, fastness and wear resistance, which increases the service life of clothes.In this project, we aim to take this project from TRL 4 to 6\. We aim to reduce the cost of the energy-intensive product separation and purification process, which counts for \>50% of the final cadaverine price. The utilization of L-lysine hydrochloride as a substrate for the production of high-purity cadaverine will be investigated by a litre-scale integrated strategy incorporating fermentation, bioproduction, deprotonation, extraction and rectification. Based on the experimental achievement on the integrated process for the production of high-purity cadaverine from lysine decarboxylase, we confirm the lab scale feasibility of a low-cost cadaverine production, which is ready for industrial-scale implementation. To scale up the production, we're aiming to achieve a 99% purity of cadaverine separation, which will offer a large potential profit margin. The price of the as-produced cadaverine is estimated to be 7 times cheaper compared to the commercially available cadaverine. We'll focus on taking this lab-scale production and theoretical simulation to an economically feasible industrial production. Most importantly, we will adopt novel digital modelling and artificial intelligence techniques developed at the University of Manchester to accelerate design and optimisation of the underlying bioprocess, so that we can further improve the sustainability and economic viability of the new bio-material manufacturing technology.
近年来,能源危机日益严重。全球变暖和化石资源短缺推动了对新生物经济的追求。身体碱是一种以生物为基础的平台化学品,在工业、医药和农业中发挥着不可或缺的作用。特别是,身体碱是聚酰胺和聚氨酯的重要聚合物单体。由于身体碱与1,6-二氨基己烷结构相似,可取代1,6-二氨基己烷合成尼龙54、尼龙56、尼龙510、尼龙512等生物基聚酰胺材料。与传统尼龙相比,由身体制成的新型尼龙具有密度更低、尺寸稳定性更好等优异性能。例如,尼龙56由于其低玻璃化转变温度和高吸水率,在生产纺织纤维方面具有显著的优势。较低的玻璃化转变温度使尼龙56纤维在高寒地区表现良好,大大提高了材料的耐低温性。高吸水率使尼龙56纤维具有良好的吸湿排汗性能,显著提高了穿着舒适性,减少了静电。此外,尼龙56具有优异的强度、牢度和耐磨性,从而延长了服装的使用寿命。在这个项目中,我们的目标是将这个项目从TRL4提高到6。我们的目标是降低能源密集型产品分离和提纯过程的成本,这一过程占最终身体价格的50%。利用L赖氨酸盐酸盐作为生产高纯度身体碱的底物,将采用发酵、生物生产、去质子化、提取和精馏相结合的升规模综合策略进行研究。基于赖氨酸脱羧酶生产高纯度身体碱一体化工艺的实验成果,我们确认了低成本生产身体碱的小试可行性,为工业化生产做好了准备。为了扩大生产规模,我们的目标是达到99%的身体分离纯度,这将提供巨大的潜在利润率。据估计,生产的身体的价格比商业上可买到的身体便宜7倍。我们将专注于将这种实验室规模的生产和理论模拟转化为经济上可行的工业生产。最重要的是,我们将采用曼彻斯特大学开发的新型数字建模和人工智能技术,以加快基础生物工艺的设计和优化,从而进一步提高新生物材料制造技术的可持续性和经济可行性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
相似海外基金
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Silica Nanocapsule-Mediated Nonviral Delivery of CRISPR Base Editor mRNA and Allele Specific sgRNA for Gene Correction in Leber Congenital Amaurosis
二氧化硅纳米胶囊介导的 CRISPR 碱基编辑器 mRNA 和等位基因特异性 sgRNA 非病毒传递用于 Leber 先天性黑蒙的基因校正
- 批准号:
10668166 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Mechanistic characterization of vaginal microbiome-metabolome associations and metabolite-mediated host inflammation
阴道微生物组-代谢组关联和代谢物介导的宿主炎症的机制特征
- 批准号:
10663410 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
缓释 PNA5 的 GMP 生产和 IND 启用研究:一种治疗阿尔茨海默氏病相关痴呆和血管性认知障碍患者认知障碍的新疗法
- 批准号:
10819329 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
XVIR-110 an ultra-long-acting INSTI for HIV pre-exposure prophylaxis in IND-enabling studies
XVIR-110 是一种超长效 INSTI,用于 IND 支持研究中的 HIV 暴露前预防
- 批准号:
10764186 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
ADEPT-STAR therapy for high risk neuroblastoma
ADEPT-STAR 治疗高危神经母细胞瘤
- 批准号:
10760738 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Laryngotracheal Reconstruction with Engineered Cartilage
用工程软骨重建喉气管
- 批准号:
10660455 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:














{{item.name}}会员




